Vendors
Latest per-thread vendor state, one row per (program, vendor, service).
9 rows
| Program | Vendor | Service | Status | Confidence | One-liner | Last substantive update | Updated |
|---|---|---|---|---|---|---|---|
| cert1 | Profluent profluent | unspecified unspecified | in_evaluation | high | AI-designed gene editor company with expertise in custom base editors for CNS disorders (e.g., RSRT/Rett collaboration). | 2026-05-07 13:06:00Z | 2026-05-13 18:58:50Z |
| syngap1 | PrimeRA Pharma Partners primara-pharma-partners | unspecified unspecified | in_evaluation | medium | Regulatory strategy consultancy engaged to perform an initial regulatory assessment for the SYNGAP1 n-of-1 ASO program. | 2026-05-08 16:15:45Z | 2026-05-13 18:58:07Z |
| cert1 | Tacit tacit | unspecified unspecified | in_evaluation | high | RNA trans-splicing platform for repairing mutant pre-mRNA without CRISPR or foreign proteins, with lead programs in Hun… | 2026-05-05 21:12:00Z | 2026-05-13 18:55:28Z |
| syngap1 | AxoLabs axolabs | unspecified unspecified | in_evaluation | medium | CRO arm of LGC Group offering ASO design, screening, and optimization (and CDMO oligonucleotide manufacturing). | 2026-05-08 23:11:00Z | 2026-05-13 18:41:26Z |
| rho-program | CD Genomics cd-genomics | unspecified unspecified | selected | high | Genomics services CRO providing PacBio HiFi long-read WGS, HMW DNA extraction, and haplotype phasing bioinformatics. | 2026-05-13 14:10:54Z | 2026-05-13 18:40:46Z |
| syngap1 | Evotec evotec | unspecified unspecified | in_evaluation | high | CRO being evaluated for splice-modulating ASO design, screening, and lead validation across two SYNGAP1 mutation progra… | 2026-05-11 23:24:49Z | 2026-05-13 18:40:16Z |
| rho-program | GenScript genscript | unspecified unspecified | in_evaluation | high | CRO providing end-to-end stable cell line generation (plasmid construction through QC) for overexpression of RHO WT and… | 2026-05-12 22:58:12Z | 2026-05-13 18:39:31Z |
| rho-program | Evotec evotec | unspecified unspecified | in_evaluation | medium | CRO partnering with Nome on an ASO (antisense oligonucleotide) discovery project for the RHO program. | 2026-04-13 23:59:00Z | 2026-05-13 18:39:05Z |
| cert1 | Editpep editpep | unspecified unspecified | prospect | low | — | — | 2026-05-13 18:37:59Z |